J.M. Extra
Impact in
- Oncology top 10%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Cancer-related Molecular Pathways
- Cancer Cells and Metastasis
-
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Papers in
- Oncology 20
- Cancer Treatment and Pharmacology 12
- Cancer Cells and Metastasis 4
- Cancer Diagnosis and Treatment 3
- HER2/EGFR in Cancer Research 2
-
- Breast Cancer Treatment Studies 8
- Cancer Genomics and Diagnostics 4
- Co-authors
- Marc Espié (10 shared papers)M. Marty (9 shared papers)Sylvie Giacchetti (5 shared papers)Véronique Dièras (4 shared papers)F. Morvan (5 shared papers)L. Mignot (3 shared papers)J-Y Pierga (3 shared papers)E. Bourstyn (7 shared papers)
In The Last Decade
J.M. Extra
32 papers receiving 416 citations
Peers
Comparison fields: 5 of 53
- Oncology 269
- Cancer Research 139
- Pathology and Forensic Medicine 95
- Internal Medicine 9
- Dermatology 23
Countries citing papers authored by J.M. Extra
This map shows the geographic impact of J.M. Extra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.M. Extra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.M. Extra more than expected).
Fields of papers citing papers by J.M. Extra
This network shows the impact of papers produced by J.M. Extra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.M. Extra. The network helps show where J.M. Extra may publish in the future.
Co-authors
The 25 scholars most cited alongside J.M. Extra, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1994 | 66 | |
| 2 | 1996 | 64 | |
| 3 | 1986 | 60 | |
| 4 | Vinorelbine (Navelbine) in the treatment of breast cancer: the European experience. | 1995 | 33 |
| 5 | 1992 | 26 | |
| 6 | 2009 | 24 | |
| 7 | Cyclophosphamide/mitoxantrone/melphalan (CMA) regimen prior to autologous bone marrow transplantation (ABMT) in metastatic breast cancer. | 1996 | 24 |
| 8 | 2014 | 20 | |
| 9 | 2004 | 15 | |
| 10 | 1994 | 12 | |
| 11 | 1991 | 12 | |
| 12 | 1999 | 10 | |
| 13 | 1997 | 10 | |
| 14 | 1996 | 9 | |
| 15 | 1999 | 9 | |
| 16 | 2013 | 8 | |
| 17 | 2001 | 6 | |
| 18 | 2004 | 6 | |
| 19 | 2001 | 4 | |
| 20 | [Promising results of bimonthly chemotherapy with high dose cyclophosphamide and epirubicin in induction treatment of inflammatory cancer of the breast]. | 1993 | 4 |
About J.M. Extra
J.M. Extra is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Reproductive Medicine, having authored 34 papers that have together received 447 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (12 papers), Breast Cancer Treatment Studies (8 papers), Cancer Genomics and Diagnostics (4 papers), Cancer Cells and Metastasis (4 papers), Ovarian cancer diagnosis and treatment (3 papers), Cancer Diagnosis and Treatment (3 papers), Advanced Breast Cancer Therapies (3 papers) and HER2/EGFR in Cancer Research (2 papers). The work is most often cited by research in Oncology (269 citations), Cancer Research (139 citations), Pathology and Forensic Medicine (95 citations), Internal Medicine (9 citations) and Dermatology (23 citations). J.M. Extra has collaborated with scholars based in France, Japan and Sweden. Frequent co-authors include Marc Espié, M. Marty, Sylvie Giacchetti, Véronique Dièras, F. Morvan, L. Mignot, J-Y Pierga, E. Bourstyn, Éric Bellissant and Fabien Calvo. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer, Annals of Oncology, European Journal of Cancer and Gynecologic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.